Esaú João - Concepedia

Author

Esaú João

Hospital Federal dos Servidores do Estado ORCID

Also Known As

E C Joao, E Joao, E João, E. C. J. Filho, E. C. Joao, E. C. João, E. C. João Filho, E. João, E.C João Filho, EC João Filho

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Hospital Federal dos Servidores do Estado Fundação Oswaldo Cruz Eunice Kennedy Shriver National Institute of Child Health and Human Development University of California, Los Angeles Westat (United States)

About

Esaú João is an author at Hospital Federal dos Servidores do Estado specializing in medicine, hiv, and maternal health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	727
2	Public Health	11	12	444
3	Epidemiology	10	10	407
4	Global Health	6	6	104
5	Social Sciences	1	1	20

Esaú João

Publications

Citations

H-Index

Page 1

	Year	Citations
Three Postpartum Antiretroviral Regimens to Prevent Intrapartum HIV Infection Karin Nielsen‐Saines, D. Heather Watts, Valdiléa G. Veloso, New England Journal of Medicine	2012	230
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19 Max R. O’Donnell, Beatriz Grinsztejn, Matthew J. Cummings, Journal of Clinical Investigation Population Health SciencesRandomized Double-blindCovid-19 EpidemiologyCovid-19Preventive Medicine	2021	170
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial Shahin Lockman, Sean S. Brummel, Lauren Ziemba, The Lancet Treatment And PreventionAntiviral Drug DevelopmentAntiviral TherapyGynecologyMaternal Health	2021	152
Chlamydia and Gonorrhea in HIV-Infected Pregnant Women and Infant HIV Transmission Kristina Adachi, Jeffrey D. Klausner, Claire Bristow, Sexually Transmitted Diseases	2015	84
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial Karin Hardt, An Vandebosch, Jerald Sadoff, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccine DevelopmentImmunologyVaccine Testing	2022	84
Syphilis in HIV-infected Mothers and Infants Nava Yeganeh, Heather Watts, Margaret Camarca, The Pediatric Infectious Disease Journal	2014	72
Pharmacokinetics and Safety of Tenofovir in HIV-Infected Women During Labor and Their Infants During the First Week of Life Mark Mirochnick, Taha E. Taha, Régis Kreitchmann, JAIDS Journal of Acquired Immune Deficiency Syndromes	2013	65
Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1-Infected Children Aged 2 Through 18 Years Sharon Nachman, Naiyu Zheng, Edward P. Acosta, Clinical Infectious Diseases	2013	59
Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected Pregnant Women and Adverse Infant Outcomes Kristina Adachi, Jeffrey D. Klausner, Jiahong Xu, The Pediatric Infectious Disease Journal	2016	59
Combined evaluation of sexually transmitted infections in HIV-infected pregnant women and infant HIV transmission Kristina Adachi, Jiahong Xu, Nava Yeganeh, PLoS ONE	2018	59

Page 1